Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., MiRNA-based antimetastasis therapy: MiRNA Let-7 suppresses the expression of PD-1 , a suppressor of activation of T-cells, via down regulation of its target gene, 4/March/2015, 14.10, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance:
It has recently been shown that blocking PD-1 with antibodies one could make tumors shrink. This work, relating to Cancer immunotherapy, has been chosen as Science’s breakthrough of the year.
The study presented here suggests that Let-7, by decreasing the expression of its target gene, it may suppress the expression of PD-1. Thereby, it may activate the immune system and inhibit metastatic progression. Thus, pharmacological formulations encompassing “Let-7 activators“ may be used to inhibit the progression of tumors.
Amount: $ 500*
Undisclosed information: How Let-7 decreases the expression of PD-1
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org